Monthly Archives: October 2011

Follow up to Funding

In a previous post, I talked about ways to change how we think about funding pancreatic cancer research.  One of the things that caught my eye was a page on the Lustgarten web site that detailed some of the significant … Continue reading

Posted in pancreatic cancer | Tagged , , , , | Leave a comment

New Pancreatic Genomics Papers

This weeks batch of papers includes an interesting review of the current treatments available for pancreatic cancer and their biomolecular targets.  We also have a number of papers on microRNA targets and their roles in sensitizing pancreatic cancer tumors to … Continue reading

Posted in pancreatic cancer | Tagged , , | Leave a comment

Latest Pancreatic Genomics Papers

In this weeks batch of papers, we have some interesting clinical trials results concerning the Ras inhibitor Salirasib and the Hedgehog inhibitor Vismodegib.  From the world of biologics, we have news of a CD40 antibody used in conjunction with gemcitabine. If … Continue reading

Posted in pancreatic cancer | Tagged , , , , | Leave a comment

New Pancreatic Cancer Drug Trials

Along with a resurgence in interest from the research and drug discovery communities in pancreatic cancer, there’s been a concomitant increase in the number of drug trials over the past couple of years. Last year, Concordia Pharmaceuticals released the results … Continue reading

Posted in Drug Development, pancreatic cancer | Tagged , , , | Leave a comment

The Time Has Come To “Think Different”

With the death of Steve Jobs, the world mourns the passing of a technological visionary who changed the world and challenged us to “Think Different”.   It seems ironic therefore, that he (along with 35,000 other Americans per year) should succumb … Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment

Latest Papers In the Pancreatic Cancer Genomics Group

Here are the latest updates to Pancreatic Cancer Genomics Group in Mendeley.  These additions included some great contributions from researchers at the Sol Goldman Institute for Pancreatic Cancer at Johns Hopkins.  There’s also some promising news from the Von Hoff … Continue reading

Posted in pancreatic cancer | Tagged , , | Leave a comment

Latest Pancreatic Cancer Genomics Papers

Here is the latest additions to the Mendeley Pancreatic Cancer Genomics papers courtesy of PubMed. Combined blockade of integrin {alpha}4{beta}1 plus cytokines SDF-1{alpha} or IL-1{beta} potently inhibits tumor inflammation and growth. AGR2 is a Novel Surface Antigen that Promotes the … Continue reading

Posted in pancreatic cancer | Tagged , | Leave a comment